Encephalitis: Clinical Trials

2 trials for Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2

Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Ofatumumab combined with daratumumab, Ofatumumab, Repeated intravenous immunoglobulin/plasma exchange therapy - Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Phase 3RecruitingThe First People's Hospital of Changzhou2002024-11-082026-06-09
Dexamethasone in Tick-borne Encephalitis
Dexametasone, Saline (0.9% NaCl) - Tick-Borne Encephalitis
Phase 3RecruitingUniversity Medical Centre Ljubljana2002024-05-032026-05-13

Narrower conditions

Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Encephalitis, Tick-Borne (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Neuroinflammatory Diseases (2)  ·  Arbovirus Infections (1)  ·  Autoimmune Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)  ·  Encephalitis, Arbovirus (1)  ·  Encephalitis, Viral (1)  ·  Flaviviridae Infections (1)  ·  Flavivirus Infections (1)  ·  Immune System Diseases (1)  ·  Infections (1)

Interventions

Sodium Chloride (1)  ·  daratumumab (1)  ·  ofatumumab (1)

Sponsors

The First People's Hospital of Changzhou (1)  ·  University Medical Centre Ljubljana (1)

Countries

China (1)  ·  Slovenia (1)

Results publications

PMID 42293080